The evaluation of γδ T-cells in COPD has been difficult as this mucosal T-cell population is relatively rare; however, it is known that in response to respiratory infection such as Streptococcus pneumoniae, γδ T-cells can become a major source of IL-17A [47]. Here, IL17A is linked to respiratory tract infectious disorder.